Biography and Research Information
OverviewAI-generated summary
Erica Lane Smith's research focuses on the development of small-molecule inhibitors, particularly targeting the RET oncoprotein in lung cancer. Her work investigates novel pyrazoloadenine compounds as potential antineoplastic agents. Smith has explored fragment optimization approaches to discover and refine these inhibitors, with a perspective on their clinical development and potential use in cancer treatment. Her research interests align with drug discovery and development, aiming to identify new therapeutic strategies for neoplasms. Smith collaborates with researchers at the University of Arkansas for Medical Sciences, including Katie R. Ryan and Brendan Frett.
Metrics
- h-index: 2
- Publications: 2
- Citations: 42
Selected Publications
-
Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development (2021)
-
Pyrazoloadenine Inhibitors of the RET Lung Cancer Oncoprotein Discovered by a Fragment Optimization Approach (2021)
Collaboration Network
Top Collaborators
Debasmita Saha
University of Arkansas for Medical Sciences (US)
2 shared publications
- Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development
- Pyrazoloadenine Inhibitors of the RET Lung Cancer Oncoprotein Discovered by a Fragment Optimization Approach
Katie R. Ryan
University of Arkansas for Medical Sciences
2 shared publications
In database
- Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development
- Pyrazoloadenine Inhibitors of the RET Lung Cancer Oncoprotein Discovered by a Fragment Optimization Approach
Naga Rajiv Lakkaniga
University of Arkansas for Medical Sciences (US)
2 shared publications
- Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development
- Pyrazoloadenine Inhibitors of the RET Lung Cancer Oncoprotein Discovered by a Fragment Optimization Approach
Brendan Frett
University of Arkansas for Medical Sciences
2 shared publications
In database
- Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development
- Pyrazoloadenine Inhibitors of the RET Lung Cancer Oncoprotein Discovered by a Fragment Optimization Approach
Baku Acharya
University of Arkansas for Medical Sciences
1 shared publication
In database
- Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development
Noemi Garcia Garcia
University of Arkansas for Medical Sciences
1 shared publication
In database
- Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development
Ermanno Florio
1 shared publication
- P552: Use of pangenome reference improves variant calling in clinical genome sequencing*
Julian Stone-Farhat
1 shared publication
- P552: Use of pangenome reference improves variant calling in clinical genome sequencing*
Matthew Schultz
1 shared publication
- P552: Use of pangenome reference improves variant calling in clinical genome sequencing*
Ali Alhafidh
1 shared publication
- P552: Use of pangenome reference improves variant calling in clinical genome sequencing*
David Brohawn
1 shared publication
- P552: Use of pangenome reference improves variant calling in clinical genome sequencing*
Marcus Mahar
1 shared publication
- P552: Use of pangenome reference improves variant calling in clinical genome sequencing*
Similar Researchers
Based on overlapping research topics
Roni M. Cox
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cancer Cells and Metastasis
Neoplasms
Sarah J. Nieman
Hendrix College
Cancer Treatment and Pharmacology
Cancer Cells and Metastasis
Zhixing Wang
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cancer Cells and Metastasis
Baha’a Jabali
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Drug Discovery
Aaron Brice
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cancer Cells and Metastasis
Hunter C Cochran
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cancer Cells and Metastasis